Dupilumab in moderate‐to‐severe prurigo nodularis: Real‐world data from early access program

Journal of the European Academy of Dermatology and Venereology 2026 Open access

Read full text
Authors: Marie Jachiet, Clementine Toussaint, Valérie Dorizy‐Vuong, Sophie Osdoit, Pierre‐André Bécherel, Emmanuelle Amazan, J. Vanlerberghe, M. Samimi, Claudia Barbosa, Carine Véra, Simmi Wiggins, Véronique Marcadé Fulcrand
+3 more Cédric Meyer, Laurent Misery, Jean‐David Bouaziz
DOI: 10.1111/jdv.70294
Cited by: 1
References: 5

Abstract

Qualified researchers may request access to patient-level data and related documents. The early access program (EAP) Protocol and the summary of the EAP report are available on the Healthcare authority website (https://www.has-sante.fr/). Patient-level data will be anonymized to protect the privacy of the EAP participants.

Fields of Study & Subjects

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Urticaria and Related Conditions

Publication details

Journal / source
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Volume
40
Issue
7
Pages
e581–e584
Publication date
7 January 2026
Language
EN